Abstract
Two monoclonal murine antibodies have been raised against a delipidated extract of human cream. These antibodies were detected by immunohistological screening of hybridoma culture supernatants on sections of human breast tissue. One of those antibodies (E29) was subsequently screened against a range of normal and neoplastic human tissues and shown to react with a wide variety of human epithelia and with mesothelial cells. Antibody E29 was unreactive with other cell types, with the exception of occasional plasma cells. Antibody E29 is suitable for use on paraffin embedded tissue and represents a valuable reagent for the identification of tumours of epithelial origin.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Cordell, J., Richardson, T., Pulford, K. et al. Production of monoclonal antibodies against human epithelial membrane antigen for use in diagnostic immunocytochemistry. Br J Cancer 52, 347–354 (1985). https://doi.org/10.1038/bjc.1985.200
Issue Date:
DOI: https://doi.org/10.1038/bjc.1985.200
This article is cited by
-
Assessment of a panel of tumor markers for the differential diagnosis of benign and malignant effusions by well-based reverse phase protein array
Diagnostic Pathology (2015)
-
Immunohistochemical profile of the dural tail in intracranial meningiomas
Acta Neurochirurgica (2014)
-
Stem cell marker TRA-1-60 is expressed in foetal and adult kidney and upregulated in tubulo-interstitial disease
Histochemistry and Cell Biology (2010)
-
KL-6 is another useful marker in assessing a micropapillary pattern in carcinomas of the breast and urinary bladder, but not the colon
Medical Molecular Morphology (2009)
-
Overexpression and altered glycosylation of MUC1 in malignant mesothelioma
British Journal of Cancer (2008)